Transforming growth factor β1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial

Growth Factor ◽

Ace Inhibitor ◽

Transforming Growth Factor ◽

Controlled Trial ◽

Transforming Growth Factor Β1 ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Randomized Controlled ◽

Renal Abnormalities

Transforming growth factor- 1 is associated with kidney damage in patients with essential hypertension: renoprotective effect of ACE inhibitor and/or angiotensin II receptor blocker

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfn159 ◽

2008 ◽

Vol 23 (9) ◽

pp. 2841-2846 ◽

Cited By ~ 19

Author(s):

S. Zhu ◽

Y. Liu ◽

L. Wang ◽

Q. H. Meng

Keyword(s):

Essential Hypertension ◽

Angiotensin Ii ◽

Growth Factor ◽

Ace Inhibitor ◽

Transforming Growth Factor ◽

Kidney Damage ◽

Receptor Blocker ◽

Angiotensin Ii Receptor Blocker ◽

Angiotensin Ii Receptor ◽

Renoprotective Effect

Platelet-Derived Growth Factor Stimulates Bone Fill and Rate of Attachment Level Gain: Results of a Large Multicenter Randomized Controlled Trial

Yearbook of Dentistry ◽

10.1016/s0084-3717(08)70367-2 ◽

2007 ◽

Vol 2007 ◽

pp. 87-88

Author(s):

A. Dentino

Keyword(s):

Growth Factor ◽

Controlled Trial ◽

Platelet Derived Growth Factor ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

Attachment Level

Faculty Opinions recommendation of Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1065847.518790 ◽

2007 ◽

Author(s):

Aimee Payne

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Controlled Trial ◽

Pemphigus Vulgaris ◽

Skin Lesions ◽

Double Blind ◽

Randomized Controlled ◽

Epidermal Growth

Effects of intravenous iron on fibroblast growth factor 23 (FGF23) in haemodialysis patients: a randomized controlled trial

BMC Nephrology ◽

10.1186/s12882-016-0391-7 ◽

2016 ◽

Vol 17 (1) ◽

Cited By ~ 16

Author(s):

Matthew A. Roberts ◽

Louis Huang ◽

Darren Lee ◽

Robert MacGinley ◽

Stefanie M. A. Troster ◽

...

Keyword(s):

Growth Factor ◽

Fibroblast Growth Factor ◽

Controlled Trial ◽

Fibroblast Growth Factor 23 ◽

Intravenous Iron ◽

Fibroblast Growth ◽

Evaluating the osteogenic potential of insulin-like growth factor-1 microspheres on osteoblastic activity around dental implants in patients with type 2 diabetes mellitus using bone scintigraphy: A split-mouth randomized controlled trial

Journal of Prosthetic Dentistry ◽

10.1016/j.prosdent.2021.06.016 ◽

2021 ◽

Author(s):

Kapil Raju ◽

Uma Maheswari Mani ◽

Anand Kumar Vaidyanathan

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Growth Factor ◽

Controlled Trial ◽

Osteogenic Potential ◽

Osteoblastic Activity ◽

Comparative study of placental α-microglobulin-1, insulin-like growth factor binding protein-1 and nitrazine test to diagnose premature rupture of membranes: A randomized controlled trial

Journal of Obstetrics and Gynaecology Research ◽

10.1111/jog.12381 ◽

2014 ◽

Vol 40 (6) ◽

pp. 1555-1560 ◽

Cited By ~ 8

Author(s):

De-ku Liang ◽

Hong-bo Qi ◽

Xin Luo ◽

Xiao-qiu Xiao ◽

Xiao-yan Jia

Keyword(s):

Growth Factor ◽

Comparative Study ◽

Binding Protein ◽

Controlled Trial ◽

Insulin Like Growth Factor ◽

Premature Rupture Of Membranes ◽

Premature Rupture ◽

Factor Binding ◽

Effects of dapagliflozin on the serum levels of fibroblast growth factor 21 and myokines and muscle mass in Japanese patients with type 2 diabetes: A randomized, controlled trial

Journal of Diabetes Investigation ◽

10.1111/jdi.13179 ◽

2019 ◽

Vol 11 (3) ◽

pp. 653-661 ◽

Cited By ~ 2

Author(s):

Hajime Yamakage ◽

Masashi Tanaka ◽

Takayuki Inoue ◽

Shinji Odori ◽

Toru Kusakabe ◽

...

Keyword(s):

Type 2 Diabetes ◽

Growth Factor ◽

Controlled Trial ◽

Japanese Patients ◽

Serum Levels ◽

Fibroblast Growth Factor 21 ◽

Fibroblast Growth ◽

Prenatal and Postnatal Milk Supplementation and Adult Insulin-like Growth Factor I: Long-term Follow-up of a Randomized Controlled Trial

Cancer Epidemiology Biomarkers & Prevention ◽

10.1158/1055-9965.epi-04-0908 ◽

2005 ◽

Vol 14 (5) ◽

pp. 1336-1339 ◽

Cited By ~ 53

Author(s):

Y. Ben-Shlomo

Keyword(s):

Growth Factor ◽

Controlled Trial ◽

Insulin Like Growth Factor ◽

Factor I ◽

Randomized Controlled ◽

Long Term Follow Up ◽

Growth Factor I

Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2006.01873.x ◽

2007 ◽

Vol 21 (1) ◽

pp. 79-84 ◽

Cited By ~ 27

Author(s):

MN Tabrizi ◽

C Chams-Davatchi ◽

N Esmaeeli ◽

P Noormohammadpoor ◽

F Safar ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Controlled Trial ◽

Pemphigus Vulgaris ◽

Skin Lesions ◽

Double Blind ◽

Randomized Controlled ◽

Epidermal Growth

Gonadotropin dependent expression of angiotensin II receptor and transforming growth factor-β1 mRNA in rat testis

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)40337-5 ◽

1998 ◽

Vol 76 ◽

pp. 54

Author(s):

Keifu Song ◽

Kei Hirai ◽

Toshikazu Watsuji ◽

Yoji Katsuoka

Keyword(s):

Angiotensin Ii ◽

Growth Factor ◽

Transforming Growth Factor ◽

Transforming Growth Factor Β1 ◽

Angiotensin Ii Receptor ◽

Rat Testis